Caretrust stock hits all-time high at 35.69 USD

Published 27/10/2025, 20:58
Caretrust stock hits all-time high at 35.69 USD

Caretrust Inc (CTRE) stock reached an all-time high of 35.69 USD, marking a significant milestone for the company. According to InvestingPro data, the company maintains impressive gross profit margins of nearly 95% and has consistently raised its dividend for nine consecutive years, currently offering a yield of 3.87%. This achievement reflects a positive trend over the past year, with the stock delivering a total return of 16.82%. The strong performance underscores investor confidence and the company’s strategic growth initiatives, supported by a robust financial health score rated as "GREAT" by InvestingPro. As Caretrust Inc continues to expand its operations and adapt to market demands, the stock’s upward trajectory highlights its resilience and potential for further growth in the healthcare real estate sector. Discover 14 additional exclusive ProTips and comprehensive analysis in the Pro Research Report, available with an InvestingPro subscription.

In other recent news, CareTrust REIT, Inc. has announced the acquisition of two care homes in the United Kingdom for approximately $27 million. These properties, which include 265 beds, will be leased to an existing operator under long-term agreements. Additionally, the company has appointed Greg Stapley to its Board of Directors, effective January 1, 2026. Stapley previously served as CareTrust’s President and CEO from 2014 to 2022. In personnel changes, CFO William Wagner plans to retire in early 2026, with Derek Bunker set to succeed him.

Analyst activities have also been noteworthy, with Cantor Fitzgerald initiating coverage of CareTrust REIT with a Neutral rating and a price target of $37.00. Meanwhile, KeyBanc has raised its price target for the company from $33.00 to $36.00, maintaining an Overweight rating. The price target adjustment follows a significant share issuance by CareTrust, which was upsized to 20 million shares, generating gross proceeds of $736 million, including the overallotment option. These developments reflect ongoing strategic and financial maneuvers by CareTrust REIT.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.